MRVI

2.95

2.79% 0.08

Dopo l'orario di chiusura: 2.95

Maravai Lifesciences Holdings Inc (MRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché MRVI Giù? Forum Previsione

Precedente Chiudi:

$2.87

Aprire:

$2.82

Volume 24 ore:

1.75M

Relative Volume:

1.27

Capitalizzazione di mercato:

$431.83M

Reddito:

$185.74M

Utile/perdita netta:

$-230.76M

Rapporto P/E:

-3.2564

EPS:

-0.9059

Flusso di cassa netto:

$-70.72M

1 W Prestazione:

-4.53%

1M Prestazione:

-18.28%

6M Prestazione:

-0.67%

1 anno Prestazione:

+33.48%

Intervallo 1D:

$2.80

$2.98

Intervallo di 1 settimana:

$2.80

$3.08

Portata 52W:

$1.665

$4.105

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Nome

Maravai Lifesciences Holdings Inc

Settore

Healthcare (1118)

Industria

Biotechnology (624)

Telefono

(858) 546-0004

Indirizzo

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Dipendente

435

Cinguettio

Prossima data di guadagno

2025-03-18

Ultimi documenti SEC

MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, INSM

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
MRVI Maravai Lifesciences Holdings Inc	2.95	431.83M	185.74M	-230.76M	-70.72M	-0.9059
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-02-26	Downgrade	Robert W. Baird	Outperform → Neutral
2024-12-19	Iniziato	Guggenheim	Neutral
2024-12-05	Downgrade	Goldman	Neutral → Sell
2024-11-14	Iniziato	Wolfe Research	Peer Perform
2024-11-08	Downgrade	William Blair	Outperform → Mkt Perform
2024-08-28	Iniziato	Wells Fargo	Overweight
2024-08-13	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Iniziato	Craig Hallum	Buy
2023-12-12	Aggiornamento	BofA Securities	Neutral → Buy
2023-08-08	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Downgrade	Credit Suisse	Outperform → Neutral
2023-05-09	Downgrade	Goldman	Buy → Neutral
2023-01-05	Downgrade	UBS	Buy → Neutral
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-07	Iniziato	RBC Capital Mkts	Outperform
2022-11-03	Downgrade	BofA Securities	Buy → Neutral
2022-08-25	Iniziato	Credit Suisse	Outperform
2021-08-05	Ripresa	Credit Suisse	Outperform
2020-12-16	Iniziato	KeyBanc Capital Markets	Overweight
2020-12-15	Iniziato	BofA Securities	Buy
2020-12-15	Iniziato	Credit Suisse	Outperform
2020-12-15	Iniziato	Goldman	Buy
2020-12-15	Iniziato	Jefferies	Buy
2020-12-15	Iniziato	Robert W. Baird	Outperform
2020-12-15	Iniziato	Stifel	Buy
2020-12-15	Iniziato	William Blair	Outperform
2020-12-14	Iniziato	UBS	Buy

Mostra tutto

Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie

Apr 03, 2026

Prestige Consumer Healthcare (NYSE:PBH) and Maravai LifeSciences (NASDAQ:MRVI) Head-To-Head Survey - Defense World

Apr 03, 2026

Apr 02, 2026

Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Apr 02, 2026

Apr 01, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 01, 2026

Mar 31, 2026

Does Maravai LifeSciences Holdings Inc have strong fundamentals2026 Volume & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 31, 2026

2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | NDAQ:MRVI | Press Release - Stockhouse

Mar 31, 2026

MRVI Stockholders Have Opportunity to Lead Maravai LifeSciences H - The National Law Review

Mar 31, 2026

Profit Review: Can Maravai LifeSciences Holdings Inc lead its sector in growth2026 Investor Takeaways & Capital Protection Trading Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Mar 30, 2026

Mar 29, 2026

How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value Targets - finance.yahoo.com

Mar 29, 2026

Mar 28, 2026

Stop Loss: Is Maravai LifeSciences Holdings Inc in a bullish channel2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 28, 2026

Mar 26, 2026

Recap Report: What is the dividend yield of Maravai LifeSciences Holdings IncGDP Growth & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Mar 26, 2026

Aug Gainers: How cyclical is CSWCs revenue stream2026 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn

Mar 26, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Mar 26, 2026

Stop Loss: What are Maravai LifeSciences Holdings Incs earnings expectationsEarnings Performance Report & Long-Term Capital Growth Strategies - baoquankhu1.vn

Mar 26, 2026

Maravai LifeSciences stock faces ongoing volatility amid restructuring efforts and biotech sector pr - AD HOC NEWS

Mar 26, 2026

Mar 25, 2026

Analysts’ Top Technology Picks: Blaize Holdings (BZAI), Zeta Global Holdings Corp (ZETA) - The Globe and Mail

Mar 25, 2026

Published on: 2026-03-25 14:27:07 - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026